Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Prothena reported $-49776000 in Pre-Tax Profit for its fiscal quarter ending in March of 2023.

Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US USD -44939000 4.05M
Agios Pharmaceuticals AGIO:US USD -81018000 117.54M
Akebia Therapeutics AKBA:US USD -26217000 18.66M
Alnylam Pharmaceuticals ALNY:US USD -172362000 34.66M
Bluebird Bio BLUE:US USD 21.24M 11.1M
Exelixis EXEL:US USD 48.28M 79.7M
Immunic Inc. VTL:US USD -25272000 31.2M
Intercept Pharmaceuticals ICPT:US USD -31881000 14.34M
Intra Cellular Therapies ITCI:US USD -44043000 17K
Ionis Pharmaceuticals IONS:US USD -113000000 81M
MacroGenics MGNX:US USD -38009000 50.81M
Nektar Therapeutics NKTR:US USD -137081000 80.54M
Neurocrine Biosciences NBIX:US USD -103300000 221.2M
Prothena PRTA:US USD -49776000 53.12M
Seattle Genetics SGEN:US USD -170113000 26.28M
Ultragenyx Pharmaceutical RARE:US USD -163477000 10.19M
Xoma XOMA:US USD -7049000 1.16M